Filed: 8/14/2024ACC: 0001013594-24-000659
📋 What this filing means
LION POINT CAPITAL, LP filed this quarterly 13F‑HR report disclosing 27 equity positions with a total reported market value of $54.85M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
27
Positions
$54.85M
Total AUM (reported)
12.92M
Total Shares
Allocation by class
COM$21.55M39.3%
RUSSELL 2000 ETF$16.74M30.5%
COM PAR $.01$4.71M8.6%
S&P BIOTECH$4.64M8.5%
COM NEW$3.20M5.8%
ORD SHS CL A$1.95M3.6%
COM SHS$1.16M2.1%
Portfolio Concentration
Top 3$27.80M50.7%
4–10$17.70M32.3%
11–25$9.31M17.0%
Rest$43.1K0.1%
Top 3 weight
50.7%
Top 10 weight
82.9%
Voting Authority Distribution
Total shares with voting rights: 12.92M
Sole
Full voting authority
12.92M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole27
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings27
Rows:
ISHARES TR
SOLEShares82.50K
TypeSH
Market value$16.74M
30.51%
Sole
82.50K
Shared
0.00
None
0.00
ARDELYX INC
SOLEShares856.67K
TypeSH
Market value$6.35M
11.57%
Sole
856.67K
Shared
0.00
None
0.00
INSMED INC
SOLEShares70.33K
TypeSH
Market value$4.71M
8.59%
Sole
70.33K
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares50K
TypeSH
Market value$4.64M
8.45%
Sole
50K
Shared
0.00
None
0.00
MILESTONE PHARMACEUTICALS IN
SOLEShares2.34M
TypeSH
Market value$3.09M
5.63%
Sole
2.34M
Shared
0.00
None
0.00
GERON CORP
SOLEShares630K
TypeSH
Market value$2.67M
4.87%
Sole
630K
Shared
0.00
None
0.00
MARINUS PHARMACEUTICALS INC
SOLEShares2.11M
TypeSH
Market value$2.47M
4.51%
Sole
2.11M
Shared
0.00
None
0.00
KINIKSA PHARMACEUTICALS INTL
SOLEShares104.69K
TypeSH
Market value$1.95M
3.56%
Sole
104.69K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares45K
TypeSH
Market value$1.54M
2.80%
Sole
45K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares65K
TypeSH
Market value$1.33M
2.43%
Sole
65K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares49K
TypeSH
Market value$1.24M
2.26%
Sole
49K
Shared
0.00
None
0.00
AVADEL PHARMACEUTICALS PLC
SOLEShares82.50K
TypeSH
Market value$1.16M
2.11%
Sole
82.50K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares8.35K
TypeSH
Market value$1.15M
2.10%
Sole
8.35K
Shared
0.00
None
0.00
FENNEC PHARMACEUTICALS INC
SOLEShares170K
TypeSH
Market value$1.04M
1.89%
Sole
170K
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares79K
TypeSH
Market value$924.3K
1.69%
Sole
79K
Shared
0.00
None
0.00
ENPHYS ACQUISITION CORP
SOLEShares78.13K
TypeSH
Market value$857.8K
1.56%
Sole
78.13K
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares32K
TypeSH
Market value$726.4K
1.32%
Sole
32K
Shared
0.00
None
0.00
BLUEBIRD BIO INC
SOLEShares678.26K
TypeSH
Market value$667.5K
1.22%
Sole
678.26K
Shared
0.00
None
0.00
BURGERFI INTERNATIONAL INC
SOLEShares2.75M
TypeSH
Market value$557.4K
1.02%
Sole
2.75M
Shared
0.00
None
0.00
REGENXBIO INC
SOLEShares36.25K
TypeSH
Market value$424.1K
0.77%
Sole
36.25K
Shared
0.00
None
0.00
SERES THERAPEUTICS INC
SOLEShares340.76K
TypeSH
Market value$246.6K
0.45%
Sole
340.76K
Shared
0.00
None
0.00
LUMOS PHARMA INC
SOLEShares90.79K
TypeSH
Market value$210.6K
0.38%
Sole
90.79K
Shared
0.00
None
0.00
MICROSOFT CORP
SOLEShares100.00
TypeSH
Market value$44.7K
0.08%
Sole
100.00
Shared
0.00
None
0.00
SPRUCE BIOSCIENCES INC
SOLEShares75K
TypeSH
Market value$38.8K
0.07%
Sole
75K
Shared
0.00
None
0.00
BURGERFI INTERNATIONAL INC
SOLEShares2.08M
TypeSH
Market value$26.3K
0.05%
Sole
2.08M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ISHARES TRSOLE | RUSSELL 2000 ETF | 82.50K | SH | $16.74M 30.51% | 82.50K | 0.00 | 0.00 |
ARDELYX INCSOLE | COM | 856.67K | SH | $6.35M 11.57% | 856.67K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 70.33K | SH | $4.71M 8.59% | 70.33K | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 50K | SH | $4.64M 8.45% | 50K | 0.00 | 0.00 |
MILESTONE PHARMACEUTICALS INSOLE | COM | 2.34M | SH | $3.09M 5.63% | 2.34M | 0.00 | 0.00 |
GERON CORPSOLE | COM | 630K | SH | $2.67M 4.87% | 630K | 0.00 | 0.00 |
MARINUS PHARMACEUTICALS INCSOLE | COM NEW | 2.11M | SH | $2.47M 4.51% | 2.11M | 0.00 | 0.00 |
KINIKSA PHARMACEUTICALS INTLSOLE | ORD SHS CL A | 104.69K | SH | $1.95M 3.56% | 104.69K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 45K | SH | $1.54M 2.80% | 45K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 65K | SH | $1.33M 2.43% | 65K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 49K | SH | $1.24M 2.26% | 49K | 0.00 | 0.00 |
AVADEL PHARMACEUTICALS PLCSOLE | COM SHS | 82.50K | SH | $1.16M 2.11% | 82.50K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 8.35K | SH | $1.15M 2.10% | 8.35K | 0.00 | 0.00 |
FENNEC PHARMACEUTICALS INCSOLE | COM | 170K | SH | $1.04M 1.89% | 170K | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 79K | SH | $924.3K 1.69% | 79K | 0.00 | 0.00 |
ENPHYS ACQUISITION CORPSOLE | CL A ORD SHS | 78.13K | SH | $857.8K 1.56% | 78.13K | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM NEW | 32K | SH | $726.4K 1.32% | 32K | 0.00 | 0.00 |
BLUEBIRD BIO INCSOLE | COM | 678.26K | SH | $667.5K 1.22% | 678.26K | 0.00 | 0.00 |
BURGERFI INTERNATIONAL INCSOLE | COM | 2.75M | SH | $557.4K 1.02% | 2.75M | 0.00 | 0.00 |
REGENXBIO INCSOLE | COM | 36.25K | SH | $424.1K 0.77% | 36.25K | 0.00 | 0.00 |
SERES THERAPEUTICS INCSOLE | COM | 340.76K | SH | $246.6K 0.45% | 340.76K | 0.00 | 0.00 |
LUMOS PHARMA INCSOLE | COM | 90.79K | SH | $210.6K 0.38% | 90.79K | 0.00 | 0.00 |
MICROSOFT CORPSOLE | COM | 100.00 | SH | $44.7K 0.08% | 100.00 | 0.00 | 0.00 |
SPRUCE BIOSCIENCES INCSOLE | COM | 75K | SH | $38.8K 0.07% | 75K | 0.00 | 0.00 |
BURGERFI INTERNATIONAL INCSOLE | *W EXP 12/16/202 | 2.08M | SH | $26.3K 0.05% | 2.08M | 0.00 | 0.00 |
Page 1 of 2